Stockreport

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF 3 min read In This Article ANVS Annovis Bio, Inc. MALVERN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Com [Read more]